Gut Microbiota and Colorectal Cancer Risk Factors

Author:

Kafil Hossein Samadi12ORCID,Feizi Hadi123,Rezaee Mohammad Ahangarzadeh1,Ghotaslou Reza1,Sadrkabir Mohammad3,Jadidi-Niaragh Farhad45,Gholizadeh Pourya1,Taghizadeh Sepehr1,Ghanbarov Khudaverdi6,Yousefi Mehdi7

Affiliation:

1. Drug Applied Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

2. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

3. Department of Internal Medicine, Islamic Azad University, Tabriz Branch, Tabriz, Iran

4. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

5. Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

6. Research Laboratory of Microbiology and Virology, Baku State University, Baku, Azerbaijan

7. Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Abstract

Abstract:: Colorectal cancer is a type of gut cancer originating either from the rectum or colon. Genetic and environmental factors, such as the gut microbiome, play pivotal roles in colorectal cancer incidence rates. Therefore, we aimed to review the risk factors of CRC comprising gut bacteriomes and their intra-interactions with each other in the context of CRC development. Gut microbiota alteration, especially bacteriome alteration as the dominant player, seems to be the common feature amongst all risk factors. Although it is not quite obvious whether these alterations are the causes or the consequences of the tumorigenesis risk factors, they are common and almost universal among CRC-affected individuals. In addition, bacterial genotoxicity, biofilm formation, oxidative stress, bacterial metabolome, and dysbiosis are assessed in CRC development. The present study suggests that gut microbial alterations could be the key intermediate, as a cause or a consequence, between most risk factors of CRC and the way they promote or contribute to CRC development.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3